India's killer snakes

Share

In India, snakebites — one of the most overlooked tropical diseases — kill more than anywhere else. But the country’s booming pharmaceutical industry could be an asset in the quest for antivenoms that are both reliable and affordable.

  • €9,922 Budget in Euros
  • 2020 Final release date
  • 3 Round winner
  • 1 Location

India's killer snakes

In India, snakebites — one of the most overlooked tropical diseases — kill more than anywhere else. But the country’s booming pharmaceutical industry could be an asset in the quest for antivenoms that are both reliable and affordable.

A scourge of poor countries, snakebites are one of the most overlooked tropical diseases. In India, they kill more than anywhere else. But in this pharmaceutical giant in the making, the snake also has the power to heal. The country can extract the venom on the spot to change it into serum. At what price? How to remove industrial, economic and cultural obstacles? This investigation follows in the footsteps of a booming production, although imperfect and unequal.

Project links

Publications

Follow us and join the conversation